Atyr Pharma Inc

NASDAQ:LIFE

1.60

-0.02 (-1.24%)

5:57:48 PM EDT: $1.63 +0.03 (+1.79%)

Market Cap (Intraday)	108.39M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.03 Million
Adjusted EPS	-$0.24

See more estimates

10-Day MA	$1.69
50-Day MA	$1.84
200-Day MA	$1.63

See more pivots

Atyr Pharma Inc Stock, NASDAQ:LIFE

10240 Sorrento Valley Road, Suite 300, San Diego, California 92121

United States of America

Phone: +1.858.731.8389

Number of Employees: 59

http://www.atyrpharma.com

Description

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.